Så kan det jo nevnes at noe annet som har forandret seg siden Q2 er at Johns Hopkins hospital i Washington har tatt BLCC som sin Standard of Care (SOC) ved diagnostisering av blærekreft.

"While the current standard of care calls for the use of white-light cystoscopy, research shows that blue-light cystoscopy — when used with a photosensitizing drug that is instilled in the bladder — improves tumor detection, which can lead to more accurate resection and lower recurrence rates.

The Greenberg Bladder Cancer Institute offers blue-light cystoscopy as a standard of care."